Endo International PLC (USD)
ENDP
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 3.28 | 3.45 |
| 52-Wk Range | - | - |
| Last Close | 3.36 |
| Mkt Cap (m) | 771.81 |
| Dividend yield | - |
| ISIN | IE00BJ3V9050 |
| Volume | 3,556,597.00 |
| Exchange Venue | NAS |
Company Profile
Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.
Key Information
| Price/Earning | - |
| Price/Book | 0.00 |
| Price/Sales | 0.25 |
| P/CF | 3.05 |
| Rev Growth (3 year avg) | -10.09 |
| EPS Growth (3 year avg) | - |
| Operating Margin % | 19.97 |
| Net Margin % | -14.50 |
| Return on Equity | - |
| Debt/Equity | - |
Documents
Prospectus
| en 08/08/2018 |
Annual Report
| en 31/12/2019 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Revenue (m) | 2,877.19 | 3,268.72 | 4,010.27 | 3,468.86 | 2,947.08 | 2,914.36 |
| Operating Income (m) | 526.58 | 349.57 | 421.20 | 438.39 | 483.53 | 581.87 |
| Net Income (m) | -721.32 | -1,495.04 | -3,347.07 | -2,035.43 | -1,031.47 | -422.64 |
| Basic EPS | -4.91 | -7.59 | -15.03 | -9.12 | -4.61 | -1.87 |
| Avg. Diluted Shares Outstanding (m) | 146.90 | 197.10 | 222.65 | 223.20 | 223.96 | 226.05 |
Balance Sheet
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Current Assets (m) | 3,307.47 | 3,475.15 | 2,589.46 | 2,271.08 | 2,343.15 | 2,586.22 |
| Non Current Assets (m) | 7,602.14 | 15,875.18 | 11,685.65 | 9,364.50 | 7,789.24 | 6,803.31 |
| Total Assets (m) | 10,909.62 | 19,350.34 | 14,275.11 | 11,635.58 | 10,132.39 | 9,389.53 |
| Current Liabilities (m) | 3,099.25 | 3,474.31 | 2,634.75 | 2,220.91 | 1,950.10 | 1,460.29 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 2,374.76 | 5,968.03 | 2,701.59 | 484.88 | -498.28 | -866.54 |
Cash Flows
| USD | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
| Operating Cash Flows (m) | 337.78 | 62.03 | 524.44 | 553.99 | 267.27 | 98.05 |
| Capital Expenditure (m) | -85.43 | -125.74 | -158.06 | -125.65 | -86.40 | -63.85 |
Figures are quoted in USD unless stated otherwise
0.04 (1.19%)
$
3.40
Last Price
© 2019 MeDirect Bank (Malta) plc. All rights reserved.